44 investors focused on Biotech targeting Belgium

Compare 44 investors focused on Biotech targeting Belgium. Review the selection, investor types and reported focus with 2080 Ventures.

By 2080 Ventures · Updated September 21, 2026

44matching investors

3individual investors

41organizations

What this selection covers

This guide contains 44 distinct directory identities matching target markets: Belgium; sectors: Biotech. Counts describe Investor Atlas coverage, not the size of the market or currently available capital.

“Targeting Belgium” means the source explicitly lists this investment market. These investors may be headquartered elsewhere. Worldwide or regional labels are not expanded into individual countries.

Investor types represented: Venture Capital (37), Corporate Venture Capital (4), Angel Investor (3), Family Office (2).

Prepare a focused approach

Explain the development pathway, validation milestones and capital needed to reach the next evidence point.

Before pitching for Belgium, confirm incorporation requirements, team location and whether the mandate supports market entry or only established local operations.

Check the current mandate and recent investments.
Confirm check size, lead or follow preference, and company eligibility.
Identify the relevant partner and published pitch route.
Explain your customer evidence, raise and specific reason for approaching this investor.

Explore the 44 matching investors

Listed alphabetically, without ranking by performance or likelihood of investment. Full profiles, investment criteria and available contact details require sign-in.

Investor	Investor type	Research
AGAgri Investment Fund	Venture Capital	View profile ↗
ALALSA Ventures	Venture Capital	View profile ↗
AMAmino Collective	Venture Capital	View profile ↗
ANAnanda Impact Ventures	Venture Capital	View profile ↗
ANAnaxago	Venture Capital	View profile ↗
ANAngular Ventures	Venture Capital	View profile ↗
ARArcTern Ventures	Venture Capital	View profile ↗
ARArdian	Private Equity	View profile ↗
ASAsabys Partners	Venture Capital	View profile ↗
ASAstanor Ventures	Venture Capital	View profile ↗
ATAtomico	Venture Capital	View profile ↗
BOBoehringer Ingelheim Venture Fund	Venture Capital, Corporate Venture Capital	View profile ↗
E-E-Merge	Venture Capital	View profile ↗
EQEQT Ventures	Venture Capital, Family Office	View profile ↗
FLFlashpoint VC	Venture Capital	View profile ↗
FLFLORA Ventures	Venture Capital	View profile ↗
FOForbion Capital Partners	Venture Capital	View profile ↗
FOFountain Healthcare Partners	Venture Capital	View profile ↗
GEGeneral Atlantic	Venture Capital	View profile ↗
GEGeneral Inception	Startup Studio	View profile ↗
GIGilde Healthcare	Venture Capital	View profile ↗
GLGlobal Founders Capital	Venture Capital, Family Office	View profile ↗
GRGreat Eagle Holdings	Corporate Venture Capital	View profile ↗
HUHummingbird Ventures	Venture Capital	View profile ↗
INIndex Ventures	Venture Capital	View profile ↗
INIndieBio	Venture Capital	View profile ↗
LULunar Ventures	Venture Capital	View profile ↗
MAMatt Sutherland	Angel Investor	View profile ↗
MIMichael Wieser	Angel Investor	View profile ↗
MIMindshift Ventures	Venture Capital	View profile ↗
NENelli Morgulchik	Angel Investor	View profile ↗
NONovo Holdings	Venture Capital, Corporate Venture Capital	View profile ↗
PAPanakes Partners	Venture Capital	View profile ↗
PFPfizer Venture Investments	Venture Capital, Corporate Venture Capital	View profile ↗
POPolaris Partners	Venture Capital	View profile ↗
PRProject A Ventures	Venture Capital	View profile ↗
QBQbic Fund	Venture Capital	View profile ↗
RIRight Side Capital Management	Venture Capital	View profile ↗
SESEE UP Accelerator	Accelerator	View profile ↗
SESeven Capital	Venture Capital	View profile ↗
SESeventure - Life Sciences	Venture Capital	View profile ↗
V-V-Bio Ventures	Venture Capital	View profile ↗
YAYaya Capital	Venture Capital	View profile ↗
ZAZAKA VC	Venture Capital	View profile ↗